VIRI - Virios Therapeutics' (VIRI) CEO Greg Duncan on Q4 2021 Results - Earnings Call Transcript

Virios Therapeutics, Inc. (VIRI) Q4 2021 Earnings Conference Call March 17, 2022 8:30 AM ET Company Participants Angela Walsh – Senior Vice President-Finance and Treasurer Greg Duncan – Chief Executive Officer Ralph Grosswald – Senior Vice President-Operations Conference Call Participants David Bautz – Zacks Small-Cap Research Sean Lee – H.C. Wainwright Presentation Operator Good morning, and welcome to Virios Therapeutics, Inc. Fourth Quarter and Year-End 2021 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode. And the floor will be open for questions and comments after the presentation. Please be advised that today's call is being recorded at the company's request. At this time, I'd like to turn the call over to Angela Walsh, Senior Vice President of Finance and Treasurer for Virios Therapeutics. Please proceed, Angela. Angela Walsh Thank you. Good morning, everyone, and thank you for joining us on today's conference

For further details see:

Virios Therapeutics' (VIRI) CEO Greg Duncan on Q4 2021 Results - Earnings Call Transcript